Summary

By 2035, the Dermal Fillers Market is expected to expand to USD 23.67 billion, reflecting a strong growth trajectory with a CAGR of 13.45% over the 2025-2035 period. Dermal fillers are non-surgical procedures that are considered minimally invasive and involve injecting a substance into the skin to remove or hide wrinkles, scars, and facial lines.

Global Shift Toward Minimally Invasive Cosmetic Solutions
The global trend towards non-surgical cosmetic procedures is one of the main elements that has been leading to the substantial growth of the dermal fillers market.

Market Segmentation
Product
- Biodegradable: Naturally absorbed, temporary aesthetic enhancement
- Non-Biodegradable: Long-lasting volume restoration solutions
Type
- Calcium Hydroxylapatite (CaHA): Stimulates collagen, deep wrinkle correction
- Hyaluronic Acid: Hydration, volume enhancement, wrinkle smoothing
- Poly-L-Lactic Acid (PLLA): Gradual collagen regeneration filler
- Polyalkylimide: Semi-permanent structural facial support
- PMMA Microspheres: Permanent filler with long-term results
- Others: Emerging materials with specialized uses
Application
- Facial Line Correction: Smoothens fine lines and wrinkles
- Face Lift: Non-surgical facial tightening solution
- Lip Enhancement: Adds volume and contour definition
- Facial Scars: Improves skin texture and appearance
- Nasolabial Folds: Reduce deep smile lines
- Others: Customized aesthetic facial treatments
End-User
- Hospitals: Advanced infrastructure and skilled surgeons
- Specialty & Dermatology Clinics: Preferred for aesthetic procedures
- Others: Medical spas and aesthetic centers

Regional Perspectives
North America and Europe still represent the largest share in the global market, while Asia-Pacific demonstrates the fastest rate of growth, and other regions are growing at a more moderate pace.

Expanding Demand and Technological Innovation
Growing demand for facial aesthetics, more aesthetic procedures, and rapid technological advancements are the main factors that are fueling the market growth.

Key Report Attributes
- Market Size 2024: USD 6,232.12 Million
- Market Size 2035: USD 23,667.64 Million
- CAGR (2025-2035): 13.45%
- Base Year: 2025
- Market Forecast Period: 2025-2035

Industry Segmentations Growth
- By Product: Biodegradable - 13.82%, Non-Biodegradable - 12.66%.
- By Type: Calcium Hydroxylapatite (CaHa) - 13.67%, Hyaluronic Acid - 14.36%.
- By Application: Facial Line Correction - 13.76%, Face lift - 13.27%.
- By End User: Hospitals - 12.93%, Specialty & Dermatology Clinics - 14.32%.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY ...... 19
2 MARKET INTRODUCTION ........ 21
2.1 DEFINITION ....... 21
SCOPE OF THE STUDY .... 21
2.2 RESEARCH OBJECTIVE ..... 21
2.3 MARKET STRUCTURE ....... 22
3 RESEARCH METHODOLOGY ....... 23
3.1 OVERVIEW .... 23
3.2 DATA FLOW ....... 25
3.2.1 DATA MINING PROCESS .... 25
3.3 PURCHASED DATABASE: ....... 26
3.4 SECONDARY SOURCES: ..... 27
3.4.1 SECONDARY RESEARCH DATA FLOW: .... 28
3.5 PRIMARY RESEARCH: ........ 29
3.5.1 PRIMARY RESEARCH DATA FLOW: ........ 30
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........ 31
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ........ 31
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ...... 32
3.6.1 REVENUE ANALYSIS APPROACH ....... 32
3.7 DATA FORECASTING..... 33
3.7.1 DATA FORECASTING TYPE ...... 33
3.8 DATA MODELING ....... 34
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 34
3.8.2 DATA MODELING: .... 35
3.9 TEAMS AND ANALYST CONTRIBUTION ....... 37
4 MARKET DYNAMICS ...... 39
4.1 INTRODUCTION ..... 39
4.2 DRIVERS .... 39
4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS ....... 39
4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS ...... 40
4.2.3 RAPID ADVANCEMENTS IN TECHNOLOGY ........ 40
4.3 RESTRAINTS ..... 41
4.3.1 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS ........ 41
4.4 OPPORTUNITY ....... 42
4.4.1 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES ........ 42
5 MARKET FACTOR ANALYSIS ....... 44
5.1 REGULATORY ENVIRONMENT & COMPLIANCE ........ 44
5.2 TECHNOLOGICAL TRENDS & INNOVATION ....... 45
5.3 PRICING ANALYSIS & REIMBURSEMENT DYNAMICS ....... 46
5.3.1 PRICING ANALYSIS ....... 46
5.3.1.1 NORTH AMERICA ...... 46
5.3.1.1.1 NORTH AMERICA PRICING ANALYSIS, BY PRODUCT ..... 46
5.3.1.2 EUROPE ..... 46
5.3.1.2.1 EUROPE PRICING ANALYSIS, BY PRODUCT.... 46
5.3.1.3 ASIA-PACIFIC ....... 47
5.3.1.3.1 ASIA-PACIFIC PRICING ANALYSIS, BY PRODUCT ..... 47
5.3.1.4 REST OF THE WORLD ...... 47
5.3.1.4.1 REST OF THE WORLD PRICING ANALYSIS, BY PRODUCT .... 47
5.3.2 REIMBURSEMENT DYNAMICS ...... 47
5.4 MARKET ENTRY & EXIT BARRIERS ...... 47
5.4.1 BARRIERS TO ENTRY .... 47
5.4.2 BARRIERS TO EXIT ........ 48
5.5 PARTNERSHIPS & COLLABORATIONS ....... 48
5.6 CONSUMER & HEALTHCARE PROVIDER PREFERENCES ....... 49
5.6.1 CONSUMER PREFERENCES ..... 49
5.6.2 HEALTHCARE PROVIDER PREFERENCES ...... 49
5.7 END USER/ CONSUMER TRENDS AND ADOPTION RATES .... 50
5.7.1 DEMOGRAPHIC SHIFTS AND AGE GROUP PREFERENCES ...... 50
5.7.2 GENDER AND DEMOGRAPHIC ADOPTION PATTERNS ....... 50
5.8 PESTLE ANALYSIS .... 51
5.8.1 POLITICAL FACTORS .... 51
5.8.2 ECONOMIC FACTORS ........ 51
5.8.3 SOCIAL FACTORS .... 51
5.8.4 TECHNOLOGICAL FACTORS .... 52
5.8.5 LEGAL FACTORS ..... 52
5.8.6 ENVIRONMENTAL FACTORS ........ 52
5.9 PORTER'S FIVE FORCES MODEL ........ 53
5.9.1 THREAT OF NEW ENTRANTS ........ 53
5.9.2 BARGAINING POWER OF SUPPLIERS ...... 53
5.9.3 THREAT OF SUBSTITUTES ...... 54
5.9.4 BARGAINING POWER OF BUYERS ...... 54
5.9.5 INTENSITY OF RIVALRY ..... 54
5.10 CASE STUDY ANALYSIS ........ 54
5.11 INVESTMENT & FUNDING SCENARIOS ..... 55
5.12 POST-MARKET SURVEILLANCE & SAFETY DATA ........ 56
6 GLOBAL DERMAL FILLER MARKET, BY PRODUCT ....... 58
6.1 OVERVIEW .... 58
6.2 BIODEGRADABLE ....... 60
6.3 NON-BIODEGRADABLE ...... 60
7 GLOBAL DERMAL FILLER MARKET, BY TYPE ..... 61
7.1 OVERVIEW .... 61
7.2 CALCIUM HYDROXYLAPATITE (CAHA) .... 64
7.3 HYALURONIC ACID ........ 64
7.4 POLY-L-LACTIC ACID (PLLA) ..... 65
7.5 POLYALKYLIMIDE .... 65
7.6 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) .... 66
7.7 OTHERS ..... 66
8 GLOBAL DERMAL FILLER MARKET, BY APPLICATION ...... 67
8.1 OVERVIEW .... 67
8.2 FACIAL LINE CORRECTION ........ 69
8.3 FACE LIFT ..... 69
8.4 LIP ENHANCEMENT ...... 70
8.5 FACIAL SCARS ....... 70
8.6 NASOLABIAL FOLDS ...... 71
8.7 OTHERS ..... 71
9 GLOBAL DERMAL FILLER MARKET, BY END USER ...... 72
9.1 OVERVIEW .... 72
9.2 HOSPITALS ........ 74
9.3 SPECIALTY & DERMATOLOGY CLINICS ..... 75
9.4 OTHERS ..... 75
10 GLOBAL DERMAL FILLERS MARKET, BY REGION ........ 76
10.1 OVERVIEW .... 76
10.2 NORTH AMERICA ...... 77
10.2.1 US....... 81
10.2.2 CANADA ....... 83
10.3 EUROPE ..... 85
10.3.1 GERMANY ..... 90
10.3.2 FRANCE ........ 92
10.3.3 UK ...... 94
10.3.4 SPAIN ...... 96
10.3.5 ITALY ....... 98
10.3.6 RUSSIA .... 100
10.3.7 REST OF EUROPE ..... 102
10.4 ASIA PACIFIC .... 104
10.4.1 CHINA ...... 108
10.4.2 INDIA ....... 110
10.4.3 JAPAN ..... 112
10.4.4 SOUTH KOREA .... 114
10.4.5 MALAYSIA .... 116
10.4.6 THAILAND ..... 118
10.4.7 INDONESIA .... 120
10.4.8 REST OF ASIA-PACIFIC ...... 122
10.5 SOUTH AMERICA ...... 124
10.5.1 BRAZIL ..... 128
10.5.2 MEXICO ........ 130
10.5.3 ARGENTINA ....... 132
10.5.4 REST OF SOUTH AMERICA ...... 134
10.6 MIDDLE EAST AND AFRICA ....... 136
10.6.1 GCC COUNTRIES...... 141
10.6.2 SOUTH AFRICA ........ 143
10.6.3 REST OF MEA ..... 145
11 COMPETITIVE LANDSCAPE .... 148
11.1 INTRODUCTION ..... 148
11.2 MARKET SHARE ANALYSIS, 2024 .... 148
11.3 COMPETITOR DASHBOARD........ 149
11.4 PUBLIC PLAYERS STOCK SUMMARY ........ 150
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ........ 150
11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ....... 150
11.1.1 PRODUCT LAUNCH ....... 150
11.1.2 ACQUISITION ..... 152
11.1.3 PRODUCT APPROVAL ........ 152
11.1.4 INNOVATION ...... 153
12 COMPANY PROFILES .... 154
12.1 GALDERMA ........ 154
12.1.1 COMPANY OVERVIEW ........ 154
12.1.2 FINANCIAL OVERVIEW ....... 155
12.1.3 PRODUCT OFFERED ...... 155
12.1.4 KEY DEVELOPMENTS .... 156
12.1.5 SWOT ANALYSIS ..... 157
12.1.6 KEY STRATEGIES ..... 157
12.2 REVANCE THERAPEUTICS ........ 158
12.2.1 COMPANY OVERVIEW ........ 158
12.2.2 FINANCIAL OVERVIEW ....... 159
12.2.3 PRODUCTS OFFERED .... 160
12.2.4 KEY DEVELOPMENTS .... 160
12.2.5 SWOT ANALYSIS ..... 161
12.2.6 KEY STRATEGIES ..... 161
12.3 ABBVIE, INC. ...... 162
12.3.1 COMPANY OVERVIEW ........ 162
12.3.2 FINANCIAL OVERVIEW ....... 163
12.3.3 PRODUCTS OFFERED .... 164
12.3.4 KEY DEVELOPMENTS .... 164
12.3.5 SWOT ANALYSIS ..... 165
12.3.6 KEY STRATEGIES ..... 165
12.4 MERZ PHARMA ..... 166
12.4.1 COMPANY OVERVIEW ........ 166
12.4.2 FINANCIAL OVERVIEW ....... 166
12.4.3 PRODUCTS OFFERED .... 167
12.4.4 KEY DEVELOPMENTS .... 167
12.4.5 KEY STRATEGIES ..... 168
12.5 SINCLAIR ....... 169
12.5.1 COMPANY OVERVIEW ........ 169
12.5.2 FINANCIAL OVERVIEW ....... 170
12.5.3 PRODUCTS OFFERED .... 170
12.5.4 KEY DEVELOPMENTS .... 170
12.5.5 KEY STRATEGIES ..... 171
12.6 DR. KORMAN ..... 172
12.6.1 COMPANY OVERVIEW ........ 172
12.6.2 FINANCIAL OVERVIEW ....... 172
12.6.3 PRODUCTS OFFERED .... 172
12.6.4 KEY DEVELOPMENTS .... 173
12.6.5 KEY STRATEGIES ..... 173
12.7 TIGER AESTHETICS MEDICAL, LLC ....... 174
12.7.1 COMPANY OVERVIEW ........ 174
12.7.2 FINANCIAL OVERVIEW ....... 174
12.7.3 PRODUCT OFFERED ...... 175
12.7.4 KEY DEVELOPMENTS .... 175
12.7.5 SWOT ANALYSIS ..... 176
12.7.6 KEY STRATEGIES ..... 176
12.8 MEDYTOX ..... 177
12.8.1 COMPANY OVERVIEW ........ 177
12.8.2 FINANCIAL OVERVIEW ....... 177
12.8.3 PRODUCTS OFFERED .... 178
12.8.4 KEY DEVELOPMENTS .... 178
12.8.5 SWOT ANALYSIS ..... 179
12.8.6 KEY STRATEGIES ..... 179
12.9 KORU PHARMA CO., LTD. ....... 181
12.9.1 COMPANY OVERVIEW ........ 181
12.9.2 FINANCIAL OVERVIEW ....... 181
12.9.3 PRODUCTS OFFERED .... 181
12.9.4 KEY DEVELOPMENTS .... 182
12.9.5 KEY STRATEGIES ..... 182
12.10 BIOPLUS CO., LTD. ...... 183
12.10.1 COMPANY OVERVIEW ........ 183
12.10.2 FINANCIAL OVERVIEW ....... 183
12.10.3 PRODUCTS OFFERED .... 183
12.10.4 KEY DEVELOPMENTS .... 184
12.10.5 KEY STRATEGIES ..... 184
13 DATA CITATIONS ...... 185

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 36
TABLE 2 GLOBAL DERMAL FILLER MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 59
TABLE 3 GLOBAL DERMAL FILLER MARKET, FOR BIODEGRADABLE, BY REGION, 2019–2035 (USD MILLION) 60
TABLE 4 GLOBAL DERMAL FILLER MARKET, FOR NON-BIODEGRADABLE, BY REGION, 2019–2035 (USD MILLION) 60
TABLE 5 GLOBAL DERMAL FILLER MARKET, BY TYPE, 2019–2035 (USD MILLION) 63
TABLE 6 GLOBAL DERMAL FILLER MARKET, FOR CALCIUM HYDROXYLAPATITE (CAHA), BY REGION, 2019–2035 (USD MILLION) 64
TABLE 7 GLOBAL DERMAL FILLER MARKET, FOR HYALURONIC ACID, BY REGION, 2019–2035 (USD MILLION) 64
TABLE 8 GLOBAL DERMAL FILLER MARKET, FOR POLY-L-LACTIC ACID (PLLA), BY REGION, 2019–2035 (USD MILLION) 65
TABLE 9 GLOBAL DERMAL FILLER MARKET, FOR POLYALKYLIMIDE, BY REGION, 2019–2035 (USD MILLION) 65
TABLE 10 GLOBAL DERMAL FILLER MARKET, FOR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA), BY REGION, 2019–2035 (USD
MILLION) 66
TABLE 11 GLOBAL DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 66
TABLE 12 GLOBAL DERMAL FILLER MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 68
TABLE 13 GLOBAL DERMAL FILLER MARKET, FOR FACIAL LINE CORRECTION, BY REGION, 2019–2035 (USD MILLION) 69
TABLE 14 GLOBAL DERMAL FILLER MARKET, FOR FACE LIFT, BY REGION, 2019–2035 (USD MILLION) 69
TABLE 15 GLOBAL DERMAL FILLER MARKET, FOR LIP ENHANCEMENT, BY REGION, 2019–2035 (USD MILLION) 70
TABLE 16 GLOBAL DERMAL FILLER MARKET, FOR FACIAL SCARS, BY REGION, 2019–2035 (USD MILLION) 70
TABLE 17 GLOBAL DERMAL FILLER MARKET, FOR NASOLABIAL FOLDS, BY REGION, 2019–2035 (USD MILLION) 71
TABLE 18 GLOBAL DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 71
TABLE 19 GLOBAL DERMAL FILLER MARKET, BY END USER, 2019–2035 (USD MILLION) 73
TABLE 20 GLOBAL DERMAL FILLER MARKET, FOR HOSPITALS, BY REGION, 2019–2035 (USD MILLION) 74
TABLE 21 GLOBAL DERMAL FILLER MARKET, FOR SPECIALTY & DERMATOLOGY CLINICS, BY REGION, 2019–2035 (USD MILLION) 75
TABLE 22 GLOBAL DERMAL FILLER MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 75
TABLE 23 GLOBAL DERMAL FILLERS MARKET, BY REGION, 2019-2035 (USD MILLION) 76
TABLE 24 NORTH AMERICA: DERMAL FILLERS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 79
TABLE 25 NORTH AMERICA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 79
TABLE 26 NORTH AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 80
TABLE 27 NORTH AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 80
TABLE 28 NORTH AMERICA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 81
TABLE 29 US: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 81
TABLE 30 US: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 82
TABLE 31 US: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 82
TABLE 32 US: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 83
TABLE 33 CANADA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 83
TABLE 34 CANADA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 84
TABLE 35 CANADA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 84
TABLE 36 CANADA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 85
TABLE 37 EUROPE: DERMAL FILLERS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 87
TABLE 38 EUROPE: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 88
TABLE 39 EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 88
TABLE 40 EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 89
TABLE 41 EUROPE: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 89
TABLE 42 GERMANY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 90
TABLE 43 GERMANY: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 90
TABLE 44 GERMANY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 91
TABLE 45 GERMANY: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 91
TABLE 46 FRANCE: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 92
TABLE 47 FRANCE: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 92
TABLE 48 FRANCE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 93
TABLE 49 FRANCE: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 93
TABLE 50 UK: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 94
TABLE 51 UK: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 94
TABLE 52 UK: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 95
TABLE 53 UK: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 95
TABLE 54 SPAIN: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 96
TABLE 55 SPAIN: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 96
TABLE 56 SPAIN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 97
TABLE 57 SPAIN: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 97
TABLE 58 ITALY: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 98
TABLE 59 ITALY: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 98
TABLE 60 ITALY: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 99
TABLE 61 ITALY: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 99
TABLE 62 RUSSIA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 100
TABLE 63 RUSSIA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 100
TABLE 64 RUSSIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 101
TABLE 65 RUSSIA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 101
TABLE 66 REST OF EUROPE: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 102
TABLE 67 REST OF EUROPE: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 102
TABLE 68 REST OF EUROPE: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 103
TABLE 69 REST OF EUROPE: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 103
TABLE 70 ASIA PACIFIC: DERMAL FILLERS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 106
TABLE 71 ASIA PACIFIC: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 106
TABLE 72 ASIA PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 107
TABLE 73 ASIA PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 107
TABLE 74 ASIA PACIFIC: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 108
TABLE 75 CHINA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 108
TABLE 76 CHINA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 109
TABLE 77 CHINA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 109
TABLE 78 CHINA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 110
TABLE 79 INDIA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 110
TABLE 80 INDIA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 111
TABLE 81 INDIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 111
TABLE 82 INDIA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 112
TABLE 83 JAPAN: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 112
TABLE 84 JAPAN: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 113
TABLE 85 JAPAN: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 113
TABLE 86 JAPAN: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 114
TABLE 87 SOUTH KOREA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 114
TABLE 88 SOUTH KOREA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 115
TABLE 89 SOUTH KOREA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 115
TABLE 90 SOUTH KOREA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 116
TABLE 91 MALAYSIA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 116
TABLE 92 MALAYSIA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 117
TABLE 93 MALAYSIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 117
TABLE 94 MALAYSIA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 118
TABLE 95 THAILAND: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 118
TABLE 96 THAILAND: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 119
TABLE 97 THAILAND: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 119
TABLE 98 THAILAND: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 120
TABLE 99 INDONESIA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 120
TABLE 100 INDONESIA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 121
TABLE 101 INDONESIA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 121
TABLE 102 INDONESIA: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 122
TABLE 103 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 122
TABLE 104 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 123
TABLE 105 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 123
TABLE 106 REST OF ASIA-PACIFIC: DERMAL FILLERS MARKET, BY END USER, 2019–2035 (USD MILLION) 124
TABLE 107 SOUTH AMERICA: DERMAL FILLERS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 126
TABLE 108 SOUTH AMERICA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 126
TABLE 109 SOUTH AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 127
TABLE 110 SOUTH AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 127
TABLE 111 SOUTH AMERICA: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION) 128
TABLE 112 BRAZIL: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 128
TABLE 113 BRAZIL: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 129
TABLE 114 BRAZIL: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 129
TABLE 115 BRAZIL: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION) 130
TABLE 116 MEXICO: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 130
TABLE 117 MEXICO: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 131
TABLE 118 MEXICO: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 131
TABLE 119 MEXICO: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION) 132
TABLE 120 ARGENTINA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 132
TABLE 121 ARGENTINA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 133
TABLE 122 ARGENTINA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 133
TABLE 123 ARGENTINA: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION) 134
TABLE 124 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 134
TABLE 125 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION) 135
TABLE 126 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 135
TABLE 127 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION) 136
TABLE 128 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY COUNTRY, 2019–2035 (USD MILLION)
TABLE 129 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 130 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 131 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, BY APPLICATION,2019–2035 (USD MILLION)
TABLE 132 MIDDLE EAST AND AFRICA: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION)
TABLE 133 GCC COUNTRIES: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 134 GCC COUNTRIES: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 135 GCC COUNTRIES: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 136 GCC COUNTRIES: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION)
TABLE 137 SOUTH AFRICA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 138 SOUTH AFRICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 139 SOUTH AFRICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 140 SOUTH AFRICA: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION)
TABLE 141 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, BY PRODUCT, 2019–2035 (USD MILLION)
TABLE 142 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, BY TYPE, 2019–2035 (USD MILLION)
TABLE 143 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, BY APPLICATION, 2019–2035 (USD MILLION)
TABLE 144 REST OF SOUTH AMERICA: DERMAL FILLERS MARKET, FOR END USER, 2019–2035 (USD MILLION)
TABLE 145 PRODUCT LAUNCH
TABLE 146 ACQUISITION
TABLE 147 PRODUCT APPROVAL
TABLE 148 INNOVATION
TABLE 149 AGREEMENT
TABLE 150 GALDERMA: PRODUCTS OFFERED
TABLE 151 GALDERMA : KEY DEVELOPMENTS
TABLE 152 REVANCE THERAPEUTICS: PRODUCTS OFFERED
TABLE 153 REVANCE THERAPEUTICS : KEY DEVELOPMENTS
TABLE 154 ABBVIE, INC.: PRODUCTS OFFERED
TABLE 155 ABBVIE, INC.: KEY DEVELOPMENTS
TABLE 156 MERZ PHARMA: PRODUCTS OFFERED
TABLE 157 MERZ PHARMA: KEY DEVELOPMENTS
TABLE 158 SINCLAIR: PRODUCTS OFFERED
TABLE 159 SINCLAIR: KEY DEVELOPMENTS
TABLE 160 DR.KORMAN: PRODUCTS OFFERED
TABLE 161 TIGER AESTHETICS MEDICAL, LLC: PRODUCTS OFFERED
TABLE 162 TIGER AESTHETICS MEDICAL, LLC: KEY DEVELOPMENTS
TABLE 163 MEDYTOX: PRODUCTS OFFERED
TABLE 164 MEDYTOX: KEY DEVELOPMENTS
TABLE 165 KORU PHARMA CO., LTD.: PRODUCTS OFFERED
TABLE 166 KORU PHARMA CO., LTD.: KEY DEVELOPMENTS
TABLE 167 BIOPLUS CO., LTD.: PRODUCTS OFFERED
TABLE 168 BIOPLUS CO., LTD.: KEY DEVELOPMENTS